Search

everythinglearnresearchcommunity

for

Search:↓

High doses of cyproterone acetate are linked to an increased risk of developing meningioma.

Pharmacists play a crucial role in safe medication use and interdisciplinary collaboration is key to reducing antimicrobial resistance.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

Biotransformed Cacumen platycladi extract promotes hair growth in mice.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.

Hair restoration surgeons must understand the differences between CTE and FPHL for accurate diagnosis and treatment.

Six months of treatment improved PCOS symptoms and reduced AMH levels.

Prednisone treatment helped a woman with Cronkhite-Canada syndrome recover from hair loss and digestive issues.

Cronkhite-Canada syndrome can cause multiple gastrointestinal polyps and various physical symptoms.

Different types of polycystic ovary syndrome show varying levels of insulin resistance, with the 'PHO' type being the most insulin resistant.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

The roadmap calls for better research and funding to improve PCOS diagnosis, treatment, and health outcomes.

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.

The author now supports the JCCP's efforts to improve non-surgical aesthetic practices after initial skepticism.

Physicians in China prioritize clinical hyperandrogenism in PCOS treatment, but clearer guidelines are needed.

Early diagnosis and nutritional support are crucial for managing Cronkhite-Canada Syndrome.

Equine Cushing's disease in horses causes hormonal imbalance, leading to symptoms like abnormal hair growth and requires lifelong treatment with pergolide.

Children and adults with Cushing's disease show different symptoms and males have more severe cases; surgery outcomes can be predicted by certain factors.

Trichoscopic features can help dermatologists distinguish between female pattern hair loss and chronic telogen effluvium.

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

CTE and FPHL are different hair loss types with unique causes.

Cronkhite-Canada syndrome causes chronic diarrhea and has a poor prognosis despite treatment.

Cicatricial pattern hair loss is likely advanced common baldness, not a type of lichen planopilaris.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Erythrocyte-anchored nanoparticles improved Cepharanthine delivery and effectiveness for treating acute lung injury.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.